Homburg, United Kingdom

Ricardo Biondi


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ricardo Biondi

Introduction

Ricardo Biondi is a notable inventor based in Homburg, GB. He has made significant contributions to the field of biochemistry, particularly in the design of compounds that modulate the activity of specific protein kinases. His work is essential for advancing therapeutic strategies in various medical conditions.

Latest Patents

Ricardo Biondi holds a patent for a method designed to select compounds based on the three-dimensional structure of phosphoinositide dependent protein kinase 1 (PDK1). This innovative method involves modeling the three-dimensional structures of multiple molecules using computer simulations. It compares these structures with a reference structure, such as the protein kinase catalytic domain of PDK1, to predict the interacting ability of the molecules. This approach also includes a method for selecting compounds that modulate the activity of hydrophobic pocket-containing protein kinases, utilizing reference structures like the phosphate binding pocket and hydrophobic pocket of PDK1.

Career Highlights

Biondi is affiliated with the Medical Research Council, where he applies his expertise in biochemistry and molecular biology. His work has implications for drug design and development, particularly in targeting protein kinases that play critical roles in cellular signaling pathways.

Collaborations

Throughout his career, Ricardo has collaborated with esteemed colleagues such as Dario Alessi and David Komander. These collaborations have further enriched his research and contributed to advancements in the understanding of protein kinases.

Conclusion

Ricardo Biondi's innovative work in the field of biochemistry, particularly his patented methods for designing compounds, showcases his significant contributions to medical research. His efforts continue to pave the way for new therapeutic approaches in treating diseases related to protein kinases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…